Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice.

The vitamin E analogue alpha-tocopheryl succinate (alpha-TOS) is an efficient anti-cancer drug. Improved efficacy was achieved through the synthesis of alpha-tocopheryl maleamide (alpha-TAM), an esterase-resistant analogue of alpha-tocopheryl maleate. In vitro tests demonstrated significantly higher cytotoxicity of alpha-TAM towards cancer cells (MCF-7, B16F10) compared to alpha-TOS and other analogues prone to esterase-catalyzed hydrolysis. However, in vitro models demonstrated that alpha-TAM was cytotoxic to non-malignant cells (e.g. lymphocytes and bone marrow progenitors). Thus we developed lyophilized liposomal formulations of both alpha-TOS and alpha-TAM to solve the problem with cytotoxicity of free alpha-TAM (neurotoxicity and anaphylaxis), as well as the low solubility of both drugs. Remarkably, neither acute toxicity nor immunotoxicity implicated by in vitro tests was detected in vivo after application of liposomal alpha-TAM, which significantly reduced the growth of cancer cells in hollow fiber implants. Moreover, liposomal formulation of alpha-TAM and alpha-TOS each prevented the growth of tumours in transgenic FVB/N c-neu mice bearing spontaneous breast carcinomas. Liposomal formulation of alpha-TAM demonstrated anti-cancer activity at levels 10-fold lower than those of alpha-TOS. Thus, the liposomal formulation of alpha-TAM preserved its strong anti-cancer efficacy while eliminating the in vivo toxicity found of the free drug applied in DMSO. Liposome-based targeted delivery systems for analogues of vitamin E are of interest for further development of efficient and safe drug formulations for clinical trials.

[1]  Yan Zhao,et al.  Vitamin E Analogs, a Novel Group of “Mitocans,” as Anticancer Agents: The Importance of Being Redox-Silent , 2007, Molecular Pharmacology.

[2]  Yan Zhao,et al.  Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate. , 2006, Molecular nutrition & food research.

[3]  A. Jordão,et al.  Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. , 2009, Leukemia research.

[4]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[5]  J. Turánek,et al.  Preparation of sterile liposomes by proliposome-liposome method. , 2003, Methods in enzymology.

[6]  T. Allen,et al.  Liposomes , 2012, Drugs.

[7]  W. Yu,et al.  Vitamin E Succinate Induces Apoptosis in Human Prostate Cancer Cells: Role for Fas in Vitamin E Succinate-Triggered Apoptosis , 2000, Nutrition and cancer.

[8]  J. Eaton,et al.  Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability. , 2002, The Biochemical journal.

[9]  M. Malafa,et al.  Vitamin E succinate inhibits colon cancer liver metastases. , 2002, The Journal of surgical research.

[10]  T. Hahn,et al.  Chemo-Immunotherapy of Breast Cancer Using Vesiculated α-Tocopheryl Succinate in Combination With Dendritic Cell Vaccination , 2005, Nutrition and cancer.

[11]  T. Idziorek,et al.  YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. , 1995, Journal of immunological methods.

[12]  F. Domann,et al.  α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II , 2008, Oncogene.

[13]  J. Neuzil,et al.  A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: A future drug against a fatal neoplastic disease? , 2004, International journal of cancer.

[14]  A. Gabizon.  Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. , 1992, Cancer research.

[15]  K. Fukuzawa,et al.  Cytotoxicity of alpha-tocopheryl succinate, malonate and oxalate in normal and cancer cells in vitro and their anti-cancer effects on mouse melanoma in vivo. , 2005, Journal of nutritional science and vitaminology.

[16]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[17]  H. Karanth,et al.  pH‐Sensitive liposomes‐principle and application in cancer therapy , 2007, The Journal of pharmacy and pharmacology.

[18]  K. Prasad,et al.  α-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review , 2003, Journal of the American College of Nutrition.

[19]  W. Yu,et al.  Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. , 1999, Nutrition and cancer.

[20]  Selective cancer cell killing by α-tocopheryl succinate , 2001, British Journal of Cancer.

[21]  E. Kanaoka,et al.  pH-sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate. , 1994, Biochimica et biophysica acta.

[22]  B. Salvatore,et al.  Vitamin E analogues as inducers of apoptosis: structure–function relation , 2003, British Journal of Cancer.

[23]  B. Salvatore,et al.  Vitamin E amides, a new class of vitamin E analogues with enhanced proapoptotic activity , 2005, International journal of cancer.

[24]  N. Davies,et al.  Pharmacokinetics and tissue distribution of d‐alpha‐tocopheryl succinate formulations following intravenous administration in the rat , 2005, Biopharmaceutics & drug disposition.

[25]  M. Hollingshead,et al.  The hollow fiber assay: continued characterization with novel approaches. , 2000, Anticancer Research.

[26]  Yan Zhao,et al.  Vitamin E analogues as anticancer agents: Lessons from studies with α‐tocopheryl succinate , 2006 .

[27]  P. Witting,et al.  α-Tocopheryl Succinate Inhibits Malignant Mesothelioma by Disrupting the Fibroblast Growth Factor Autocrine Loop , 2005, Journal of Biological Chemistry.

[28]  K. Agrawal,et al.  Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E. , 1991, Experimental hematology.

[29]  A. Vacek,et al.  Restoration of femoral GM-CFC progenitors in sublethally irradiated mice of various ages treated with liposomal adamantylamide dipeptide. , 2004, International immunopharmacology.

[30]  J. Neuzil,et al.  α-Tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-κB activation , 2003, British Journal of Cancer.

[31]  M. Malafa,et al.  Vitamin E inhibits melanoma growth in mice. , 2002, Surgery.

[32]  Marc Birringer,et al.  A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression. , 2007, Cancer research.

[33]  R. Cardiff,et al.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M R Grever,et al.  In vivo cultivation of tumor cells in hollow fibers. , 1995, Life sciences.

[35]  R. Coffey,et al.  Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  L. Mayer,et al.  Pulsed exposure of SDZ PSC 833 to multidrug resistant P388/ADR and MCF7/ADR cells in the absence of anticancer drugs can fully restore sensitivity to doxorubicin. , 1997, Anticancer research.

[37]  N. Phillips,et al.  Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome. , 1992, Blood.

[38]  D. Rotkovská,et al.  Radioprotection of hemopoiesis conferred by aqueous extract from chlorococcal algae (Ivastimul) administered to mice before irradiation. , 1990, Experimental hematology.

[39]  Jizomoto Hiroaki,et al.  pH-Sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate , 1994 .

[40]  M. Garg,et al.  Reduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomes , 2006, Journal of drug targeting.

[41]  T. Hahn,et al.  Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. , 2006, Cancer research.

[42]  D. Bearss,et al.  α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells , 2004, Cancer Immunology, Immunotherapy.

[43]  Xiu-fang Wang,et al.  Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. , 2007, Cancer research.

[44]  O. Glatter,et al.  Lipoprotein-associated α-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells , 2000 .

[45]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[46]  Xiu-fang Wang,et al.  Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. , 2007, Molecular aspects of medicine.

[47]  S. Clarke,et al.  Developments in drug delivery: implications for cancer care , 2003, Current opinion in oncology.

[48]  R. Coffey,et al.  Induction of cancer cell apoptosis by α‐tocopheryl succinate: molecular pathways and structural requirements , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  W. Yu,et al.  RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. , 1997, Nutrition and cancer.